All In Biotech

Drug Trial Radar · NCT07339423

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Obesity (AMAZE 1)

Last checked: Nov 20, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,150 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,150

Planned (sponsor's estimate)

Start

Feb 24, 2026

Primary completion

Jun 26, 2029

Study completion Aug 21, 2029

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Jan 14, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.

Conditions

  • Obesity

Interventions

  • NNC0487-0111Drug

    NNC0487-0111 will be administered subcutaneously using PDS290 pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

  • Placebo (matched to NNC0487-0111)Drug

    Placebo matched to NNC0487-0111 will be administered subcutaneously using PDS290 pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change in body weightTime frame: From baseline (week 0) to week 84

Locations

72 sites in 9 countries. Site status is shown where the registry gives one.

  • South Broward Research LLC

    Miramar, Florida · Recruiting

  • Clinical Neuroscience Solution

    Orlando, Florida · Recruiting

  • Hope Clin Res & Wellness

    Conyers, Georgia · Recruiting

  • Endeavor Health

    Skokie, Illinois · Recruiting

  • Midwest Inst For Clin Res

    Indianapolis, Indiana · Recruiting

  • StudyMetrix Research LLC

    City of Saint Peters, Missouri · Recruiting

  • New York Gastroenterology Associates

    New York, New York · Recruiting

  • UNC Eastowne Medical Office

    Chapel Hill, North Carolina · Recruiting

  • PharmQuest Life Sciences LLC

    Greensboro, North Carolina · Recruiting

  • Accellacare and KDCILM, LLC

    Wilmington, North Carolina · Recruiting

  • UPA Ctr Weight and Eating Dis

    Philadelphia, Pennsylvania · Recruiting

  • Clinical Res Collaborative

    Cumberland, Rhode Island · Recruiting

  • Medical Uni of SC Charleston

    Charleston, South Carolina · Recruiting

  • Coastal Carolina Research Ctr

    North Charleston, South Carolina · Recruiting

  • Hillcrest Clinical Research

    Simpsonville, South Carolina · Recruiting

  • Amarillo Medical Specialists

    Amarillo, Texas · Recruiting

  • Velocity Clinical Res-Dallas

    Dallas, Texas · Recruiting

  • Care United Research, LLC

    Forney, Texas · Recruiting

  • Washington Cntr Weight Mgmt

    Arlington, Virginia · Recruiting

  • Health Res of Hampton Roads

    Newport News, Virginia · Recruiting

  • Selma Medical Associates

    Winchester, Virginia · Recruiting

  • Rainier Clin Res Ctr Inc

    Renton, Washington · Recruiting

  • Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli

    Buenos Aires, Argentina · Recruiting

  • Instituto de Investigaciones Clínicas Córdoba

    Córdoba, Argentina · Recruiting

  • Sanatorio Esperanza

    Esperanza, Santa Fe, Argentina · Recruiting

  • CIPADI

    Godoy Cruz, Argentina · Recruiting

  • Instituto de Investigaciones Clinicas San Nicolás

    San Nicolás, Argentina · Recruiting

  • Fundación CESIM

    Santa Rosa, La Pampa Province, Argentina · Recruiting

  • Sydney Clinical Trials

    Campbelltown, New South Wales, Australia · Recruiting

  • Sydney Cardiometabolic Centre

    Liverpool, New South Wales, Australia · Recruiting

  • Hunter Diabetes Centre

    Merewether, New South Wales, Australia · Recruiting

  • Heart of Australia

    Chelmer, Queensland, Australia · Recruiting

  • HUB - Hôpital Erasme

    Brussels, Belgium · Recruiting

  • UZA - UZ Antwerpen - Department of Endocrinology

    Edegem, Belgium · Recruiting

  • Universitair Ziekenhuis Gent

    Ghent, Belgium · Recruiting

  • UZ Leuven - Endocrinology

    Leuven, Belgium · Recruiting

  • MECLINAS

    Mechelen, Belgium · Recruiting

  • AZ Delta - Roeselare

    Roeselare, Belgium · Recruiting

  • C-Health Partners

    Calgary, Alberta, Canada · Recruiting

  • Ocean West Research Clinic

    Surrey, British Columbia, Canada · Recruiting

Showing 40 of 72 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.